Parmax Pharma Share Price

Incorporated in Nov.94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmaxs pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The Company then discontinued their business activities for few years due to various reasons. Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994 the Company had set up a plant to manufacture and market bulk drugs like amoxycillin trihydrate, ampicillin trihydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA. Antibiotic project was fully implemented from 31st May97.

As of 7 Mar 2026, Parmax Pharma share price is ₹32.7. The stock opened at ₹32.9 and had closed at ₹32.4 the previous day. During today’s trading session, Parmax Pharma share price moved between ₹30.85 and ₹32.92, with an average price for the day of ₹31.89. Over the last 52 weeks, the stock has recorded a low of ₹28.00 and a high of ₹55.02. In terms of performance, Parmax Pharma share price has declined by 8.5% over the past six months and has declined by 18.86% over the last year.